APPLICATION
ANDA063001
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-06
LATEST ACTION
2000-02-01
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
AMOXICILLINDiscontinued
AMOXICILLIN 250MG/5ML · FOR SUSPENSION · ORAL
Approval history
2000-02-01Labeling · Supplement 10AP
1999-07-07Labeling · Supplement 8AP
1998-01-15Manufacturing (CMC) · Supplement 7AP
1996-09-13Manufacturing (CMC) · Supplement 6AP
1995-02-24Manufacturing (CMC) · Supplement 4AP
1994-02-23Manufacturing (CMC) · Supplement 5AP
1993-05-27Manufacturing (CMC) · Supplement 3AP
1993-05-27Manufacturing (CMC) · Supplement 2AP
1992-03-24Manufacturing (CMC) · Supplement 1AP
1989-01-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.